Cas:88536-11-2 4-n-Propoxypiperidine manufacturer & supplier

We serve Chemical Name:4-n-Propoxypiperidine CAS:88536-11-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4-n-Propoxypiperidine

Chemical Name:4-n-Propoxypiperidine
CAS.NO:88536-11-2
Synonyms:MFCD06248727;4-propoxypiperidine
Molecular Formula:C8H17NO
Molecular Weight:143.22700
HS Code:2933399090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:194.654ºC at 760 mmHg
Density:0.913g/cm3
Index of Refraction:1.453
PSA:21.26000
Exact Mass:143.13100
LogP:1.49380

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like MFCD06248727 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-propoxypiperidine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-propoxypiperidine Use and application,MFCD06248727 technical grade,usp/ep/jp grade.


Related News: It is frequently associated with the presence of blasts or leukemic cells in the marrow. 4-n-Propoxypiperidine manufacturer Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS). 4-n-Propoxypiperidine supplier The company reported that it was cooperating with the Justice Department probe and that an outside law firm was also “investigating these allegations thoroughly.” 4-n-Propoxypiperidine vendor Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS). 4-n-Propoxypiperidine factory The foundational patent, which expires in 2034, is owned by MSK and is licensed exclusively to Fate Therapeutics for all human therapeutic uses.